{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:29:10Z","timestamp":1757618950938,"version":"3.44.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"U.S. Centers for Disease Control and Prevention.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10400-8","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T06:18:19Z","timestamp":1752646699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination"],"prefix":"10.1038","volume":"15","author":[{"given":"Wanitchaya","family":"Kittikraisak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaniya","family":"Leepiyasakulchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chutiphon","family":"Saelee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuleekorn","family":"Tanathitikorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patama","family":"Suttha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somsak","family":"Punjasamanvong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phunlerd","family":"Piyaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanapat","family":"Wongrapee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornsak","family":"Yoocharoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suthat","family":"Chottanapund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"10400_CR1","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s11033-022-08193-4","volume":"50","author":"S Borkotoky","year":"2023","unstructured":"Borkotoky, S., Dey, D. & Hazarika, Z. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective. Mol. Biol. Rep. 50, 2713\u20132721. https:\/\/doi.org\/10.1007\/s11033-022-08193-4 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"10400_CR2","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41385-022-00569-w","volume":"15","author":"M Yaugel-Novoa","year":"2022","unstructured":"Yaugel-Novoa, M., Bourlet, T. & Paul, S. Role of the humoral immune response during COVID-19: Guilty or not guilty?. Mucosal. Immunol. 15, 1170\u20131180. https:\/\/doi.org\/10.1038\/s41385-022-00569-w (2022).","journal-title":"Mucosal. Immunol."},{"key":"10400_CR3","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1172\/jci142804","volume":"130","author":"M Secchi","year":"2020","unstructured":"Secchi, M. et al. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J. Clin. Invest. 130, 6366\u20136378. https:\/\/doi.org\/10.1172\/jci142804 (2020).","journal-title":"J. Clin. Invest."},{"key":"10400_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158-168.e114. https:\/\/doi.org\/10.1016\/j.cell.2020.08.017 (2020).","journal-title":"Cell"},{"key":"10400_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000514202","volume":"182","author":"M Rezaei","year":"2021","unstructured":"Rezaei, M., Marjani, M., Mahmoudi, S., Mortaz, E. & Mansouri, D. Dynamic changes of lymphocyte subsets in the course of COVID-19. Int. Arch. Allergy Immunol. 182, 254\u2013262. https:\/\/doi.org\/10.1159\/000514202 (2021).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10400_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jlb.3covr0520-272r","volume":"108","author":"J Wang","year":"2020","unstructured":"Wang, J., Jiang, M., Chen, X. & Montaner, L. J. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc Biol. 108, 17\u201341. https:\/\/doi.org\/10.1002\/jlb.3covr0520-272r (2020).","journal-title":"J. Leukoc Biol."},{"key":"10400_CR7","unstructured":"World Health Organization. COVID-19 advice for the public: Getting vaccinated. (2024). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines\/advice#:~:text=In%20September%202024%2C%20WHO\u2019s%20Strategic,comorbidities%2C%20immunocompromised%20individuals%20and%20pregnant."},{"key":"10400_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jmii.2023.01.011","volume":"56","author":"T Pienthong","year":"2023","unstructured":"Pienthong, T. et al. Risk categorization and outcomes among healthcare workers exposed to COVID-19: A cohort study from a Thai tertiary-care center. J. Microbiol. Immunol. Infect. 56, 537\u2013546. https:\/\/doi.org\/10.1016\/j.jmii.2023.01.011 (2023).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10400_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/vaccines10050639","volume":"10","author":"W Jantarabenjakul","year":"2022","unstructured":"Jantarabenjakul, W. et al. Dynamics of neutralizing antibody and T-cell responses to SARS-CoV-2 and variants of concern after primary immunization with CoronaVac and booster with BNT162b2 or ChAdOx1 in health care workers. Vaccines Basel 10, 639. https:\/\/doi.org\/10.3390\/vaccines10050639 (2022).","journal-title":"Vaccines Basel"},{"key":"10400_CR10","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1016\/j.vaccine.2023.06.017","volume":"41","author":"S Makanut","year":"2023","unstructured":"Makanut, S., Wangteeraprasert, A., Jitpewngam, W., Ngoenkam, J. & Pongcharoen, S. Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine Naresuan University. Vaccine 41, 4335\u20134340. https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.017 (2023).","journal-title":"Vaccine"},{"key":"10400_CR11","doi-asserted-by":"publisher","first-page":"100277","DOI":"10.1016\/j.jvacx.2023.100277","volume":"13","author":"U Phumisantiphong","year":"2023","unstructured":"Phumisantiphong, U. et al. Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford-AstraZeneca vaccines in healthcare workers in Thailand. Vaccine X 13, 100277. https:\/\/doi.org\/10.1016\/j.jvacx.2023.100277 (2023).","journal-title":"Vaccine X"},{"key":"10400_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/irv.12975","volume":"16","author":"W Kittikraisak","year":"2022","unstructured":"Kittikraisak, W. et al. Anti-SARS-CoV-2 IgG antibody levels among Thai healthcare providers receiving homologous and heterologous COVID-19 vaccination regimens. Influenza Other Respir Viruses 16, 662\u2013672. https:\/\/doi.org\/10.1111\/irv.12975 (2022).","journal-title":"Influenza Other Respir Viruses"},{"key":"10400_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/s0140-6736(22)00094-0","volume":"399","author":"SA Costa-Clemens","year":"2022","unstructured":"Costa-Clemens, S. A. et al. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): A phase 4, non-inferiority, single blind, randomised study. Lancet 399, 521\u2013529. https:\/\/doi.org\/10.1016\/s0140-6736(22)00094-0 (2022).","journal-title":"Lancet"},{"key":"10400_CR14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jmii.2023.10.001","volume":"56","author":"K Intawong","year":"2023","unstructured":"Intawong, K. et al. Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4\/BA.5 omicron predominance in Thailand. J. Microbiol. Immunol. Infect. 56, 1178\u20131186. https:\/\/doi.org\/10.1016\/j.jmii.2023.10.001 (2023).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10400_CR15","doi-asserted-by":"publisher","first-page":"2037384","DOI":"10.1080\/21645515.2022.2037384","volume":"18","author":"E Jamshidi","year":"2022","unstructured":"Jamshidi, E. et al. Longevity of immunity following COVID-19 vaccination: A comprehensive review of the currently approved vaccines. Hum. Vaccin. Immunother. 18, 2037384. https:\/\/doi.org\/10.1080\/21645515.2022.2037384 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"10400_CR16","doi-asserted-by":"publisher","first-page":"103539","DOI":"10.1016\/j.ebiom.2021.103539","volume":"70","author":"A Zollner","year":"2021","unstructured":"Zollner, A. et al. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19. EBioMedicine 70, 103539. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103539 (2021).","journal-title":"EBioMedicine"},{"key":"10400_CR17","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.4049\/jimmunol.2200525","volume":"209","author":"S Mise-Omata","year":"2022","unstructured":"Mise-Omata, S. et al. Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and responsiveness to the omicron variant. J. Immunol. 209, 2104\u20132113. https:\/\/doi.org\/10.4049\/jimmunol.2200525 (2022).","journal-title":"J. Immunol."},{"key":"10400_CR18","doi-asserted-by":"publisher","first-page":"e0254563","DOI":"10.1371\/journal.pone.0254563","volume":"16","author":"W Kittikraisak","year":"2021","unstructured":"Kittikraisak, W. et al. Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak. PLoS ONE 16, e0254563. https:\/\/doi.org\/10.1371\/journal.pone.0254563 (2021).","journal-title":"PLoS ONE"},{"key":"10400_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41541-024-00867-3","volume":"9","author":"RW Titball","year":"2024","unstructured":"Titball, R. W. et al. Progress with COVID vaccine development and implementation. NPJ Vaccines 9, 69. https:\/\/doi.org\/10.1038\/s41541-024-00867-3 (2024).","journal-title":"NPJ Vaccines"},{"key":"10400_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/v15030624","author":"AA Al-Fattah Yahaya","year":"2023","unstructured":"Al-Fattah Yahaya, A. A., Khalid, K., Lim, H. X. & Poh, C. L. Development of next generation vaccines against SARS-CoV-2 and variants of concern. Viruses https:\/\/doi.org\/10.3390\/v15030624 (2023).","journal-title":"Viruses"},{"key":"10400_CR21","doi-asserted-by":"publisher","first-page":"2411059","DOI":"10.4014\/jmb.2411.11059","volume":"35","author":"JB Ndzouboukou","year":"2025","unstructured":"Ndzouboukou, J. B., Kamara, A. A., Ullah, N., Lei, Q. & Fan, X. L. A meta-analysis on the immunogenicity of homologous versus heterologous immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA1 VoCs in healthy adults. J. Microbiol. Biotechnol. 35, 2411059. https:\/\/doi.org\/10.4014\/jmb.2411.11059 (2025).","journal-title":"J. Microbiol. Biotechnol."},{"key":"10400_CR22","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/vaccines10101708","volume":"10","author":"A Abdollahi","year":"2022","unstructured":"Abdollahi, A., Afsharyzad, Y., Vaezi, A. & Meysamie, A. Importance of the COVID-19 vaccine booster dose in protection and immunity. Vaccines (Basel) 10, 1708\u20131717. https:\/\/doi.org\/10.3390\/vaccines10101708 (2022).","journal-title":"Vaccines (Basel)"},{"key":"10400_CR23","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3390\/vaccines11071196","volume":"11","author":"MK Verheul","year":"2023","unstructured":"Verheul, M. K. et al. Booster immunization improves memory B cell responses in older adults unresponsive to primary SARS-CoV-2 immunization. Vaccines Basel 11, 1196. https:\/\/doi.org\/10.3390\/vaccines11071196 (2023).","journal-title":"Vaccines Basel"},{"key":"10400_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.988536","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. The role of B cells in COVID-19 infection and vaccination. Front. Immunol. 13, 988536. https:\/\/doi.org\/10.3389\/fimmu.2022.988536 (2022).","journal-title":"Front. Immunol."},{"key":"10400_CR25","doi-asserted-by":"publisher","first-page":"6950","DOI":"10.1126\/sciimmunol.abi6950","volume":"6","author":"RR Goel","year":"2021","unstructured":"Goel, R. R. et al. Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination. Sci. Immunol. 6, 6950\u20136969. https:\/\/doi.org\/10.1126\/sciimmunol.abi6950 (2021).","journal-title":"Sci. Immunol."},{"key":"10400_CR26","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1126\/science.abh1282","volume":"372","author":"CJ Reynolds","year":"2021","unstructured":"Reynolds, C. J. et al. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science 372, 1418\u20131423 (2021).","journal-title":"Science"},{"key":"10400_CR27","doi-asserted-by":"publisher","first-page":"103659","DOI":"10.1016\/j.isci.102021.103659","volume":"25","author":"S Winklmeier","year":"2022","unstructured":"Winklmeier, S. et al. Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG. Science 25, 103659. https:\/\/doi.org\/10.1016\/j.isci.102021.103659 (2022).","journal-title":"Science"},{"key":"10400_CR28","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.lana.2022.100296","volume":"12","author":"A Paternina-Caicedo","year":"2022","unstructured":"Paternina-Caicedo, A. et al. Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study. Lancet Reg Health Am 12, 100296. https:\/\/doi.org\/10.1016\/j.lana.2022.100296 (2022).","journal-title":"Lancet Reg. Health Am."},{"key":"10400_CR29","doi-asserted-by":"publisher","first-page":"105479","DOI":"10.1016\/j.isci.102022.105479","volume":"25","author":"FX Gao","year":"2022","unstructured":"Gao, F. X. et al. Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice. Science 25, 105479. https:\/\/doi.org\/10.1016\/j.isci.102022.105479 (2022).","journal-title":"Science"},{"key":"10400_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","volume":"35","author":"A Schietinger","year":"2014","unstructured":"Schietinger, A. & Greenberg, P. D. Tolerance and exhaustion: Defining mechanisms of T cell dysfunction. Trends Immunol. 35, 51\u201360 (2014).","journal-title":"Trends Immunol."},{"key":"10400_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/14760584.2022.2071705","volume":"21","author":"MA Azim-Majumder","year":"2022","unstructured":"Azim-Majumder, M. A. & Razzaque, M. S. Repeated vaccination and \u201cvaccine exhaustion\u201d: relevance to the COVID-19 crisis. Expert Rev Vaccines 21, 1011\u20131014 (2022).","journal-title":"Expert Rev Vaccines"},{"key":"10400_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109177","volume":"245","author":"M Alahdal","year":"2022","unstructured":"Alahdal, M. & Elkord, E. Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities. Clin. Immunol. 245, 109177. https:\/\/doi.org\/10.1016\/j.clim.2022.109177 (2022).","journal-title":"Clin. Immunol."},{"key":"10400_CR33","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"key":"10400_CR34","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1038\/s41467-022-32324-x","volume":"13","author":"M Reinscheid","year":"2022","unstructured":"Reinscheid, M. et al. COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation. Nat Commun 13, 4631. https:\/\/doi.org\/10.1038\/s41467-022-32324-x (2022).","journal-title":"Nat. Commun."},{"key":"10400_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41564-022-01106-y","volume":"7","author":"J Lang-Meli","year":"2022","unstructured":"Lang-Meli, J. et al. SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals. Nat. Microbiol. 7, 675\u2013679 (2022).","journal-title":"Nat. Microbiol."},{"key":"10400_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-021-03841-4","volume":"597","author":"V Oberhardt","year":"2021","unstructured":"Oberhardt, V. et al. Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature 597, 268\u2013273 (2021).","journal-title":"Nature"},{"key":"10400_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/trstmh\/trab045","volume":"115","author":"EM Choi","year":"2021","unstructured":"Choi, E. M. COVID-19 vaccines for low- and middle-income countries. Trans. R Soc. Trop. Med. Hyg. 115, 447\u2013456 (2021).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"10400_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijid.2021.07.033","volume":"110","author":"PT Soe","year":"2021","unstructured":"Soe, P. T. et al. Circulating IgA\/IgG memory B cells against Mycobacterium tuberculosis dormancy-associated antigens Rv2659c and Rv3128c in active and latent tuberculosis. Int. J. Infect. Dis. 110, 75\u201382 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"10400_CR39","doi-asserted-by":"publisher","first-page":"102130","DOI":"10.1016\/j.xpro.2023.102130","volume":"4","author":"A Rouers","year":"2023","unstructured":"Rouers, A., Tay, M. Z., Ng, L. F. P. & Renia, L. B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain. STAR Protoc 4, 102130. https:\/\/doi.org\/10.1016\/j.xpro.2023.102130 (2023).","journal-title":"STAR Protoc"},{"key":"10400_CR40","doi-asserted-by":"publisher","first-page":"109823","DOI":"10.1016\/j.celrep.2021.109823","volume":"37","author":"KA Pape","year":"2021","unstructured":"Pape, K. A. et al. High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines. Cell Rep. 37, 109823. https:\/\/doi.org\/10.1016\/j.celrep.2021.109823 (2021).","journal-title":"Cell Rep."},{"key":"10400_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","volume":"595","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature 595, 421\u2013425. https:\/\/doi.org\/10.1038\/s41586-021-03647-4 (2021).","journal-title":"Nature"},{"key":"10400_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","volume":"607","author":"F Muecksch","year":"2022","unstructured":"Muecksch, F. et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost. Nature 607, 128\u2013134. https:\/\/doi.org\/10.1038\/s41586-022-04778-y (2022).","journal-title":"Nature"},{"key":"10400_CR43","doi-asserted-by":"publisher","first-page":"109320","DOI":"10.1016\/j.celrep.2021.109320","volume":"35","author":"J Pusnik","year":"2021","unstructured":"Pusnik, J. et al. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help. Cell Rep 35, 109320. https:\/\/doi.org\/10.1016\/j.celrep.2021.109320 (2021).","journal-title":"Cell Rep"},{"key":"10400_CR44","doi-asserted-by":"publisher","first-page":"e046676","DOI":"10.1136\/bmjopen-2020-046676","volume":"11","author":"T Nopsopon","year":"2021","unstructured":"Nopsopon, T., Pongpirul, K., Chotirosniramit, K. & Hiransuthikul, N. COVID-19 seroprevalence among hospital staff and preprocedural patients in Thai community hospitals: a cross-sectional study. BMJ Open 11, e046676. https:\/\/doi.org\/10.1136\/bmjopen-2020-046676 (2021).","journal-title":"BMJ Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10400-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10400-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10400-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:47:39Z","timestamp":1757245659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10400-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10400"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10400-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Boards (IRBs) of Department of Disease Control of the Thai Ministry of Public Health and four participating hospitals (Bamrasnaradura Infectious Diseases Institute; Phaholpolpayuhasena hospital; Phramongkutklao hospital [PMK], and Rayong hospital). The IRBs of the U.S. Centers for Disease Control and Prevention and Mahidol University relied on the determinations made by the PMK\u2019s and MOPH\u2019s IRBs, respectively. All participants provided written informed consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"25713"}}